Industry To FDA: Limit Scope Of Branding Provision To Reprocessed Devices

Financial and logistical concerns with the Medical Device User Fee & Modernization Act provision stipulating that all devices must "conspicuously bear" their manufacturer's name, abbreviation or symbol have prompted industry reps to call for an amendment narrowing the scope

More from Archive

More from Medtech Insight